# Study of Telbivudine and Lamivudine to Prevent Vertical Transmission of Hepatitis B

> **NCT01743079** · PHASE4 · COMPLETED · sponsor: **Beijing YouAn Hospital** · enrollment: 700 (actual)

## Conditions studied

- Chronic Hepatitis B
- Late Pregnancy
- Transmission
- Complication

## Interventions

- **DRUG:** Telbivudine
- **DRUG:** Lamivudine

## Key facts

- **NCT ID:** NCT01743079
- **Lead sponsor:** Beijing YouAn Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-01
- **Primary completion:** 2013-07
- **Final completion:** 2013-07
- **Target enrollment:** 700 (ACTUAL)
- **Last updated:** 2013-07-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01743079

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01743079, "Study of Telbivudine and Lamivudine to Prevent Vertical Transmission of Hepatitis B". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01743079. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*